Your browser doesn't support javascript.
loading
A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages.
Swets, Maaike C; Moss, Rob J; Kor, Flip; Hilarius, Doranne; Moes, Dirk Jan A R; Berkhout, Willemijn Em; van den Toorn, Leon M; van den Oever, Niels C Gritters; de Valk, Renee; Rosendaal, Frits R; Hunfeld, Nicole; Groeneveld, Geert H; de Boer, Mark G J.
Afiliación
  • Swets MC; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: m.c.swets@lumc.nl.
  • Moss RJ; Dutch National Medication Coordination Centre, The Hague, The Netherlands.
  • Kor F; LOGEX, Amsterdam, The Netherlands.
  • Hilarius D; Department of Pharmacy, Red Cross Hospital, Beverwijk, The Netherlands.
  • Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Berkhout WE; LOGEX, Amsterdam, The Netherlands.
  • van den Toorn LM; Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • van den Oever NCG; Department of Intensive Care Medicine, Treant Hospitals, Emmen, The Netherlands.
  • de Valk R; LOGEX, Amsterdam, The Netherlands.
  • Rosendaal FR; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Hunfeld N; Department of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Groeneveld GH; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands; Department of Internal Medicine- Acute Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands.
  • de Boer MGJ; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: m.g.j.de_boer@lumc.nl.
Int J Infect Dis ; 129: 57-62, 2023 Apr.
Article en En | MEDLINE | ID: mdl-36738957
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article Pais de publicación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2023 Tipo del documento: Article Pais de publicación: Canadá